Cyclophosphamide (oral metronomic)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cyclophosphamide (oral metronomic), covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]